Bare Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4K Hold
1,013
0.01% 109
2025
Q4
$25.2K Hold
1,013
0.01% 111
2025
Q3
$25.8K Sell
1,013
-74
-7% -$1.83K 0.01% 112
2025
Q2
$26.3K Buy
1,087
+100
+10% +$2.33K 0.01% 96
2025
Q1
$25K Hold
987
0.01% 80
2024
Q4
$26.2K Hold
987
0.01% 76
2024
Q3
$28.6K Hold
987
0.01% 74
2024
Q2
$30.1K Buy
987
+887
+887% +$24.4K 0.02% 70
2024
Q1
$2.56K Hold
100
﹤0.01% 111
2023
Q4
$2.88K Buy
+100
New +$3.02K 0.01% 95

Other funds holding PFE

Bare Financial Services's PFE Position: Q1 2026 in Review

Bare Financial Services held its Pfizer (PFE) position steady in Q1 2026 at 1,013 shares worth $28.4K. The position accounts for 0.01% of the portfolio, ranked #109.

Bare Financial Services first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $30.1K in Q2 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bare Financial Services held 1,013 shares of Pfizer worth $28.4K as of Q1 2026.
  • Bare Financial Services left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.01% of Bare Financial Services's portfolio in Q1 2026, its #109 holding.
  • Bare Financial Services first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Bare Financial Services's Pfizer position peaked at $30.1K in Q2 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.